皮佩拉西林在胆汁和胆汁系统的点组织中达到高度:在猪身上进行的一项实验研究
Louise L Pontoppidan1,2, Mats Bue3,4, Kim C Houlind2,5
1Department of Surgery, Lillebaelt Hospital, Kolding, Denmark.
Antimicrobial agents and chemotherapy
|August 18, 2025
概括
皮佩拉西林/塔扎巴克坦 (TZP) 通过保持比细菌最小抑制度 (MIC) 以上的皮佩拉西林度,有效治疗胆道感染. 这项对猪的研究证实了长时间暴露在胆汁中的皮佩拉西林,这对于有效治疗至关重要.
科学领域:
- 药理学 药理学是指药理学的学科.
- 传染性疾病 传染性疾病
- 手术科学 手术科学
背景情况:
- 皮佩拉西林/塔扎巴克坦 (TZP) 是治疗胆道感染的关键抗生素.
- 抗生素的有效性与超过最小抑制度 (T > MIC) 的时间相关.
- 常见的胆道病原体的MIC为8和16μg/mL.
研究的目的:
- 用微透析在猪胆道系统中评估皮佩拉西林T>MIC.
- 为了评估与8,16和32μg/mL的MIC目标相对应的piperacillin度.
- 为了比较胆汁的药理动力学与血和组织度.
主要方法:
- 在猪中,微透析导管放置在肝脏,胆囊壁/胆中,以及常见胆道壁/胆中.
- 静脉注射TZP (4/0.5g),然后进行8小时的采样.
- 超高性能液体染色学 (UHPLC) 用于皮佩拉西林的量化.
主要成果:
- 平均T>MIC在不同MIC目标 (8,16,32μg/mL) 中的范围为42%至99%.
- 与血和组织相比,胆汁表现出更高的AUC0-8h,Cmax和更长的T1/2.
- 皮皮拉西林在胆汁中实现了长时间的T>MIC,所有测试的MIC的近100%.
结论:
- 皮佩拉西林在胆道系统中表现出有利的药理动力学特性,特别是在胆道中.
- 达到T>MIC表明TZP是有效治疗由易受病原体引起的胆道感染.
- 微透析是评估胆道系统中点药物度的一个有价值的工具.
相关概念视频
Methods for Studying Drug Absorption: In situ
In situ experiments, such as the Doluisio method and Single-Pass Perfusion technique, provide critical insights into drug uptake by simulating in vivo conditions for drug absorption.
The Doluisio method involves perfusing a prepared segment of a rat's small intestine with a solution of radiolabeled drug and a non-absorbable marker. This helps to differentiate between absorbed and non-absorbed drug concentrations. The intestinal segment is connected at both ends using tubing and syringes,...
The Doluisio method involves perfusing a prepared segment of a rat's small intestine with a solution of radiolabeled drug and a non-absorbable marker. This helps to differentiate between absorbed and non-absorbed drug concentrations. The intestinal segment is connected at both ends using tubing and syringes,...
Hepatic Drug Excretion: Enterohepatic Cycling
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Hepatic Drug Excretion: Influencing Factors
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion, mediated...
A recent model describes pravastatin's hepatobiliary excretion, mediated...


